Sterility Indicators Market Worth $1.24 Billion by 2025

The global sterility indicators market size is expected to reach USD 1.24 billion by 2025, according to the study performed by Grand View Research, Inc. It is anticipated to expand at a CAGR of 10.9% over the forecast period. Strict regulations regarding healthcare products and high emphasis on sterility parameters and measures for the prevention of Hospital Acquired Infections (HAIs) are projected to drive the market growth.

Increasing number of geriatric population prone to chronic conditions is primarily driving the demand for drugs and medical devices globally.Governments in developing economies like India and China are focusing on providing cost-effective, high quality medications. The Union Cabinet of India has provided USD 13.16 billion to the National Health Mission (NHM) from April 2017 to March 2020. Currently, India has the highest U.S. Food and Drug Administration (FDA)-approved manufacturing facilities outside U.S. It also accounts for 22.0% of the overall approved U.S. FDA plants. Thus, demand for sterility testing services and products is anticipated to rise over the forecast period.

Standardized manufacturing protocols, introduction of novel products, and adoption of new technologies has led to harmonization of quality and sterility testing standards in the healthcare industry. This has created a need for not only aseptic manufacturing techniques but also for efficient and reliable sterilization monitoring processes. Furthermore, organizations such as the Agency for Healthcare Research and Quality and Centers for Medicare and Medicaid Services are also raising awareness about the need for stringent regulations for safety and quality testing services of healthcare products. Such steps are anticipated to bode well for expansion of the sterility indicators market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sterility-indicators-market

Further key findings from the report suggest:

Biological indicator segment captured the largest market share in 2017. Extensive usage as compared to chemical indicators owing to their reliability is anticipated to propel the segment growth
North America is expected to maintain its dominance with the largest market share over the forecast period owing to the presence of a large number of major companies and a high adoption of advanced technologies
Asia Pacific is expected to exhibit a lucrative CAGR during the forecast period. Presence of a large untapped market and availability of supportive government regulations are expected to attract global players
Some of the major players in the sterility indicators market include Getinge AB; Cantel Medical Corporation; 3M Company; Cardinal Health Inc.; Matachana Group; Mesa Laboratories; and Anderson Products Inc.

Antibody Production Market Worth $22.6 Billion By 2025

The global antibody production market size is expected to reach a value of USD 22.6 billion by 2025, at a CAGR of 13.5% according to a new report by Grand View Research, Inc. Increasing demand for therapeutic antibodies including monoclonal and polyclonal antibodies is a major factor that drives the growth of the market during the forecast period. Antibodies are the dominant biopharmaceuticals that specifically target the abnormal cells. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced antibodies for the treatment of chronic diseases such as cancer, rheumatic heart disease, and arthritis.

Patent expiry of several blockbuster monoclonal antibodies in the near future is another major factor supporting market growth. Several antibodies such as Avastin, Herceptin, and Mabthera are going to lose their patents in a few years. For instance, the patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is expected to propel the demand for antibody production products.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/antibody-production-market

Further key findings from the study suggest:

Downstream processing was the largest revenue-grossing segment of the antibody production market in 2016. It is also expected to exhibit the highest CAGR during the forecast period, owing to the large application of chromatography devices and resins in downstream processing
The monoclonal antibody segment was leading in 2016, due to its higher demand in treatment of chronic diseases including cancer, blood disorders, and growth hormone deficiency
The pharmaceutical and biotechnology companies segment dominated the overall market in terms of revenue in 2016, owing to the large production of therapeutic antibodies and high investment in R&D by companies for drug development
North America was the largest revenue-generating region of the market in the year 2016. This region is expected to maintain its position during the forecast period because of the presence of several leading biopharmaceuticals and biotechnology companies in this region
Asia Pacific region is projected to be the fastest-growing segment over the study period, due to rapidly booming biotechnology industry and comparatively less stringent regulations for biologics development in APAC region
Some of the key players include GE Healthcare; Thermo Fisher Scientific, Inc.; Sartorius AG; Merck KGaA; Pall Corp.; Eppendorf AG; Cellab GmbH; INTEGRA Biosciences AG; and FiberCell Systems Inc.

Synthetic Fibers Market Size Worth $88.5 Billion By 2025

The global synthetic fiber market size is expected to reach USD 88.5 billion by 2025, expanding at a CAGR of 6.3% over the forecast period, according to a new report by Grand View Research, Inc. The superior chemical, physical and mechanical properties of synthetic fibers are further expected to propel the demand over the forecast period.

In terms of revenue, polyester was the largest segment in 2016 and the trend is anticipated to continue at a growth rate of 6.3% over the forecast period. The useful chemical properties such as resistance to moisture, chemical, and abrasion are expected to boost the demand among the consumers over the forecast period. Polyester has been extensively used in clothing applications on account durability, wrinkle, and stain resistance. The polyester when mixed with other synthetic fibers improves the surface appearance as it imparts high luster.

Synthetic fiber is used in various applications, such as clothing, home furnishing, automotive, and filtration, as it imparts useful functional properties including heat and moisture resistance. The increasing spending capability of customers toward purchasing attractive clothing is expected to trigger the demand for various types of synthetic fibers. These factors together are anticipated to boost demand over the forecast period.

The demand for synthetic fiber will further be driven by the growth in clothing in developed economies including the U.S., Germany, the UK, and France. E. I. du Pont de Nemours and Company announced the addition of two new testing facilities in Brazil and Singapore to test and analyze the performance of fire protective apparels. The addition of these facilities will bring the company’s total lab count to five. Other companies in synthetic fiber business are also undergoing expansion on account of increased demand from developed economies.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/synthetic-fibers-market

Further key findings from the report suggest:

The polyester segment is expected to experience the fastest growth, in terms of volume, at a CAGR of 5.4% from 2017 to 2025 as polyester finds application in various end-use industries such as clothing, home furnishing, automotive and filtration
Clothing was estimated as the largest application due to different types of segments across various geographies
The U.S. synthetic fiber market, in terms of revenue, was valued at USD 4,301.6 million in 2016 and is estimated to reach USD 6,776.7 million by 2025. The clothing industry in the U.S. is projected to witness the fastest growth over the next eight years owing to the increasing demand from customers
Key players including Toray Industries, Inc., E. I. du Pont de Nemours, and Company, Lenzing AG, Indorama Corporation, Mitsubishi Chemical Holdings Corporation, Reliance Industries Limited, and China Petroleum Corporation have a prominent presence in the global synthetic fiber market